Right now, about 12% of American aged 18 or older (or 1 in 8 adults) are taking GLP-1 (glucagon-like peptide-1) receptor agonists – medications that were initially developed and FDA-approved to treat type 2 diabetes are also being used off-label for weight loss beyond medical need.. Wegovy, Ozempic, Mounjaro, Trulicity and other similar drugs work by…

Read More